Evaluate the Efficacy and Safety of CTO0307 in Adults With Presbyopia

NCT07723716 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Presbyopia

Interventions

DRUG: CTO0307 Eye drop
DRUG: Vehicle (Placebo solution)

Sponsor

Taejoon Pharmaceutical Co., Ltd.